Literature DB >> 14693238

Investigation of CXCR4 in squamous cell carcinoma of the tongue.

Cagri B Delilbasi1, Masaya Okura, Seiji Iida, Mikihiko Kogo.   

Abstract

Cancer metastasis is not a random process and different cancer types have favorite metastatic sites. Recent studies on metastasis have focused on chemoattraction, particularly on the role of chemokines. Therefore, in this study we investigated whether CXCR4 (receptor for stromal cell-derived factor-1) is expressed in squamous cell carcinoma of the tongue. For this purpose, immunohistochemical staining was performed on 26 sections obtained from 23 patients (15 patients having tongue tumor without lymph node metastasis and eight patients having lymph node metastasis). All tumor cells expressed CXCR4, whereas normal mucosa of the tongue had no or faint expression CXCR4. Metastatic tumor cells in lymph nodes had stronger expression than primary tongue tumor cells. Our data raises the possibility that CXCR4 could be involved in lymph node metastasis of oral squamous cell carcinoma.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14693238     DOI: 10.1016/s1368-8375(03)00144-1

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  12 in total

1.  The expression and role of stromal cell-derived factor-1alpha-CXCR4 axis in human dental pulp.

Authors:  Long Jiang; Ya-Qin Zhu; Rong Du; Ying-Xin Gu; Lie Xia; Feng Qin; Helena H Ritchie
Journal:  J Endod       Date:  2008-08       Impact factor: 4.171

Review 2.  Chemokines, chemokine receptors and the gastrointestinal system.

Authors:  Hiroshi Miyazaki; Kazuaki Takabe; W Andrew Yeudall
Journal:  World J Gastroenterol       Date:  2013-05-21       Impact factor: 5.742

3.  Gene Expression Signatures of Lymph Node Metastasis in Oral Cancer: Molecular Characteristics and Clinical Significances.

Authors:  Xiqiang Liu; Antonia Kolokythas; Jianguang Wang; Hongzhang Huang; Xiaofeng Zhou
Journal:  Curr Cancer Ther Rev       Date:  2010-11-01

4.  SDF-1alpha promotes invasion of head and neck squamous cell carcinoma by activating NF-kappaB.

Authors:  Aasia O Rehman; Cun-Yu Wang
Journal:  J Biol Chem       Date:  2008-04-30       Impact factor: 5.157

5.  CXCR4-gp120-IIIB interactions induce caspase-mediated apoptosis of prostate cancer cells and inhibit tumor growth.

Authors:  Shailesh Singh; Vincent C Bond; Michael Powell; Udai P Singh; Harvey L Bumpers; William E Grizzle; James W Lillard
Journal:  Mol Cancer Ther       Date:  2009-01       Impact factor: 6.261

6.  Exposure to chewing tobacco promotes primary oral squamous cell carcinoma and regional lymph node metastasis by alterations of SDF1α/CXCR4 axis.

Authors:  Sudipta Ray; Depanwita Saha; Neyaz Alam; Saunak Mitra Mustafi; Shyamsundar Mandal; Aniruddha Sarkar; Biswanath Majumder; Nabendu Murmu
Journal:  Int J Exp Pathol       Date:  2021-03-03       Impact factor: 1.925

7.  Analysis of chemokine and chemokine receptor expression in squamous cell carcinoma of the head and neck (SCCHN) cell lines.

Authors:  Hendrik A Wolff; David Rolke; Margret Rave-Fränk; Markus Schirmer; Wolfgang Eicheler; Annegret Doerfler; Andrea Hille; Clemens F Hess; Christoph Matthias; Ralph M W Rödel; Hans Christiansen
Journal:  Radiat Environ Biophys       Date:  2010-11-18       Impact factor: 1.925

Review 8.  Chemokine function in periodontal disease and oral cavity cancer.

Authors:  Sinem Esra Sahingur; W Andrew Yeudall
Journal:  Front Immunol       Date:  2015-05-05       Impact factor: 7.561

9.  CCR7 and CXCR4 Expression in Primary Head and Neck Squamous Cell Carcinomas and Nodal Metastases – a Clinical and Immunohistochemical Study

Authors:  Maya Al-Jokhadar; Ahmad Al-Mandily; Khaled Zaid; Elie Azar Maalouf
Journal:  Asian Pac J Cancer Prev       Date:  2017-04-01

10.  The tumor microenvironment contribution to development, growth, invasion and metastasis of head and neck squamous cell carcinomas.

Authors:  Sittichai Koontongkaew
Journal:  J Cancer       Date:  2013-01-01       Impact factor: 4.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.